Need for circular use of materials in construction Construction and demolition waste are being recycled on a large scale to use as a foundation for e.g. roads, but recycled building materials are hardly ever used in the construction of buildings.
Breakthrough on cumulative risk assessment exposure to pesticides in food The European Commission, Member States and EFSA have taken a major step forward in their work on assessing the cumulative risks from exposure to pesticides in food.
Tool for risk assessment of nanomaterials in cosmetics Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.
New possibilities for the responsible recycling of plastics RIVM proposes the consideration of a broader environmental perspective in the trade-off between incineration or recycling of plastics.
Priorities for science and society about the influence of ecosystems on well-being An international network of researchers has set new priorities for science and society in the area of ecosystems and their influence on social well-being.
Ebola information for GPs RIVM has sent a message to Community Health Services (GGD's) containing information about how issues concerning Ebola are arranged in the Netherlands.
Possibly more cases of gastroenteritis caused by antacids In recent years the Netherlands has witnessed an increase in the number of cases of gastroenteritis caused by the Campylobacter bacterium.
Annual report RIVM 2013 online In our annual report, we look back at compelling RIVM projects and research in 2013.
Ongoing Ebola outbreak West Africa August 8th the World Health Organization declared the Ebola outbreak in West Africa an international health emergency and appealed for global aid to help afflicted countries.
Is screening for sexually transmitted infections as part of HIV care cost-effective in the Netherlands? Routine screening for anorectal chlamydia among HIV-positive men who have sex with men (MSM) could avert further spread of chlamydia and HIV in the total MSM population.